ORITAVANCIN
UNII PUG62FRZ2E

Substance Identification & Data

This profile provides standardized clinical and technical data for Oritavancin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PUG62FRZ2E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 171099-57-3 and the RxNorm Concept ID (RxCUI) 1547611. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
PUG62FRZ2E
CAS Registry Number
171099-57-3
RxNorm Concept ID

Detailed Substance Profile

Preferred Name
ORITAVANCIN
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
PUG62FRZ2E
The specific atomic composition represented as a molecular structure string.
InChIKey
C86H97Cl3N10O26
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
VHFGEBVPHAGQPI-LXKZPTCJSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
INN ID
7979
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
O=C1[C@@]2([H])c3cc(Oc4ccc([C@H]([C@]5(C(=O)N[C@]([H])(C(=O)O)c6cc(O)cc(O)c6-c7c(O)ccc(c7)[C@@]([H])(N1)C(=O)N5)[H])O[C@@]8([H])C[C@](C)(N)[C@@H](O)[C@H](C)O8)cc4Cl)c(O[C@H]9[C@H](O[C@]%10([H])O[C@@H](C)[C@H](O)[C@](NCc%11ccc(-c%12ccc(Cl)cc%12)cc%11)(C)C%10)[C@@H](O)[C@H](O)[C@@H](CO)O9)c(c3)Oc%13ccc(cc%13Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(=O)N)C(=O)N2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Oritavancin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ORITAVANCIN

Common Names & Synonyms

(4''R)-22-O-(3-AMINO-2,3,6-TRIDEOXY-3-C-METHYL-.ALPHA.-L-ARABINO-HEXOPYRANOSYL)-N(SUP 3)''-(P-(P-CHLOROPHENYL)BENZYL)VANCOMYCIN
ORITAVANCIN [INN]
ORITAVANCIN [MART.]
ORITAVANCIN [MI]
ORITAVANCIN [VANDF]
ORITAVANCIN [WHO-DD]

Systematic Nomenclature

VANCOMYCIN, 22-O-(3-AMINO-2,3,6-TRIDEOXY-3-C-METHYL-.ALPHA.-L-ARABINO-HEXOPYRANOSYL)-N3''-((4'-CHLORO(1,1'-BIPHENYL)-4-YL)METHYL)-, (4''R)-

Technical Codes

LY333328
LY-333328

NDC Products Containing ORITAVANCIN

This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory: